- Home
- PBYI vs AMPY Comparison
PBYI vs AMPY Comparison
Compare PBYI & AMPY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PBYI
- AMPY
- Stock Information
- Founded
- PBYI 2010
- AMPY 2011
- Country
- PBYI United States
- AMPY United States
- Employees
- PBYI N/A
- AMPY N/A
- Industry
- PBYI Biotechnology: Pharmaceutical Preparations
- AMPY Oil & Gas Production
- Sector
- PBYI Health Care
- AMPY Energy
- Exchange
- PBYI Nasdaq
- AMPY Nasdaq
- Market Cap
- PBYI 154.1M
- AMPY 157.7M
- IPO Year
- PBYI N/A
- AMPY 2011
- Fundamental
- Price
- PBYI $3.14
- AMPY $3.89
- Analyst Decision
- PBYI Strong Buy
- AMPY Strong Buy
- Analyst Count
- PBYI 1
- AMPY 3
- Target Price
- PBYI $7.00
- AMPY $10.00
- AVG Volume (30 Days)
- PBYI 418.2K
- AMPY 597.2K
- Earning Date
- PBYI 05-01-2025
- AMPY 03-05-2025
- Dividend Yield
- PBYI N/A
- AMPY N/A
- EPS Growth
- PBYI 37.78
- AMPY N/A
- EPS
- PBYI 0.62
- AMPY 0.31
- Revenue
- PBYI $230,468,000.00
- AMPY $294,680,100.00
- Revenue This Year
- PBYI N/A
- AMPY $26.99
- Revenue Next Year
- PBYI $3.27
- AMPY $21.93
- P/E Ratio
- PBYI $5.06
- AMPY $12.55
- Revenue Growth
- PBYI N/A
- AMPY 1.72
- 52 Week Low
- PBYI $2.23
- AMPY $3.54
- 52 Week High
- PBYI $6.06
- AMPY $8.15
- Technical
- Relative Strength Index (RSI)
- PBYI 45.33
- AMPY 38.15
- Support Level
- PBYI $3.14
- AMPY $3.72
- Resistance Level
- PBYI $3.56
- AMPY $4.06
- Average True Range (ATR)
- PBYI 0.19
- AMPY 0.19
- MACD
- PBYI -0.05
- AMPY 0.06
- Stochastic Oscillator
- PBYI 17.54
- AMPY 34.00
About PBYI Puma Biotechnology Inc
Puma Biotechnology Inc is a biopharmaceutical company that develops and commercializes innovative products to enhance cancer care and improve treatment outcomes for patients. It is currently commercializing NERLYNX, an oral version of neratinib, for the treatment of HER2-positive breast cancer. Also it develops alisertib. Alisertib is a selective, small-molecule inhibitor of aurora kinase A that is designed to disrupt mitosis leading to apoptosis of rapidly proliferating tumor cells that are dependent on aurora kinase A.
About AMPY Amplify Energy Corp.
Amplify Energy Corp is an independent oil and natural gas company engaged in the acquisition, development, exploitation, and production of oil and natural gas properties in the United States. The company's oil and natural gas properties are located in large, mature oil and natural gas reservoirs. The company assets consists of producing oil and natural gas properties located in Oklahoma, the Rockies, federal waters offshore Southern California, East Texas/North Louisiana and Eagle Ford.